EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside Ro Targets BCAT1/2 to Suppress Ferroptosis: A Novel Therapeutic Strategy for Ischemic Cardioprotection

Jincheng Liu, Feng Wang, Juan Bai, Sujun Qu, Saiqun Tao, Chenhui Liu, Qin Wang, Wenwen Ding, Qiong Lai, Jie Zhang iD

Journal of Agricultural and Food Chemistry · 2025

DOI: 10.1021/acs.jafc.5c04774 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Jincheng Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jingmen Central Hospital, Jingmen Central Hospital Affiliated to Jingchu University of Technology, Shenzhen Avenue, Duodao Di…. Hauptthemen laut MEDLINE: Ginsenosides, Ferroptosis, Cardiotonic Agents, Myocardial Ischemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Jingmen Science and Technology Bureau, Natural Science Foundation of Jiangsu Province, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesFerroptosisCardiotonic AgentsMyocardial IschemiaTransaminasesAnimalsRatsMiceMaleMyocytes, CardiacNF-E2-Related Factor 2HumansMice, Inbred C57BLRats, Sprague-DawleyKelch-Like ECH-Associated Protein 1Panax

Stichwörter der Autor:innen

BCAT1/2Keap1/Nrf2/HO-1 pathwayferroptosisginsenoside Romyocardial ischemia

Substanzen

GinsenosidesCardiotonic AgentsTransaminasesNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1

Autor:innen und Institutionen

  • Department of Pharmacy, Jingmen Central Hospital, Jingmen Central Hospital Affiliated to Jingchu University of Technology, Shenzhen Avenue, Duodao District, Jingmen, Hubei 448000, China.
  • Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu 215008, China.
  • Medical College of Jingchu University of Technology, Jingmen, Hubei 448000, China.
  • The MOE Key Laboratory of Standardization of Chinese Medicines, The SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, The Shanghai Key Laboratory for Compound Chinese Medicines, Institut…

ORCID-Profile: Jie Zhang

Förderung

  • Jingmen Science and Technology Bureau
  • Natural Science Foundation of Jiangsu Province
  • Natural Science Foundation of Hubei Province
  • Hubei Provincial Department of Education
  • National Natural Science Foundation of China
  • Applied Foundational Research of Medical and Health Care of Suzhou City
  • Gusu Health Talent Program of Suzhou

Zitieren

APA

Liu, J., Wang, F., Bai, J., Qu, S., Tao, S., Liu, C., Wang, Q., Ding, W., Lai, Q., & Zhang, J. (2025). Ginsenoside Ro Targets BCAT1/2 to Suppress Ferroptosis: A Novel Therapeutic Strategy for Ischemic Cardioprotection. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c04774

Vancouver

Liu J, Wang F, Bai J, Qu S, Tao S, Liu C, et al. Ginsenoside Ro Targets BCAT1/2 to Suppress Ferroptosis: A Novel Therapeutic Strategy for Ischemic Cardioprotection. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.5c04774

BibTeX
@article{Liu2025,
  author = {Liu, Jincheng and Wang, Feng and Bai, Juan and Qu, Sujun and Tao, Saiqun and Liu, Chenhui and Wang, Qin and Ding, Wenwen and Lai, Qiong and Zhang, Jie},
  title = {Ginsenoside Ro Targets BCAT1/2 to Suppress Ferroptosis: A Novel Therapeutic Strategy for Ischemic Cardioprotection},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2025},
  doi = {10.1021/acs.jafc.5c04774}
}
Kostenlos starten →